AIG
BBC icon

American International Group’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

American International Group’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-250
Closed -$7K – 5026
2015
Q4 		$7K Hold
250
– – ﹤0.01% 4615
2015
Q3 		$7K Hold
250
– – ﹤0.01% 4577
2015
Q2 		$9.05K Buy
+250
New +$8.6K ﹤0.01% 4627

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

American International Group's BBC Position: Q1 2016 in Review

American International Group sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2016, closing a stake of 250 shares — an estimated $7K sold.

American International Group first reported a position in BBC in Q2 2015 and held it in 3 quarters. The position peaked at $9.05K in Q2 2015. 12 funds tracked by Wall St. Rank hold BBC as of Q1 2016.

  • American International Group reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2016 after selling out during the quarter.
  • American International Group sold 250 Virtus Biotech Clinical Trials ETF shares in Q1 2016, an estimated $7K.
  • American International Group first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2015 and held it in 3 quarters.
  • American International Group's Virtus Biotech Clinical Trials ETF position peaked at $9.05K in Q2 2015.
  • 12 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2016.

Based on American International Group's 13F filing for Q1 2016, filed 12 May 2016.